No Detail Found!

Granulocyte-colony Stimulating Factor in Neonatal Sepsis with Leukopenia: a Prospective Cohort Study.

Author(s)
Asad Maqbool Ahmad Military Hospital, Rawalpindi (Army Medical Corps), Rawalpindi, Pakistan
Zeeshan Ahmed Military Hospital, Rawalpindi (Army Medical Corps), Rawalpindi, Pakistan
Talal Waqar Combined Military Hospital, Rawalpindi (Army Medical Corps), Rawalpindi, Pakistan
Arshad Khushdil Military Hospital, Rawalpindi (Army Medical Corps), Rawalpindi, Pakistan
Abstract
Objectives: To observe the duration for normalization of the Total Leucocyte Count (TLC) with adjuvant Granulocyte-Colony Stimulating Factor (G-CSF) treatment in leukopenic neonatal sepsis, and to compare the neutrophilic response to G-CSF in neutropenic vs non-neutropenic subgroups Methods: This prospective cohort study was carried out at the Neonatal Intensive Care Unit at Military Hospital Rawalpindi (NICU) from 1st August 2015 to 25th January 2017. Fifty one newborns with sepsis and leucopenia were sampled judgmentally from a population of 5666 admitted to NICU during the study period. The sample was then divided into neutropenic (exposed) and non-neutropenic (non-exposed) subgroups on basis of the absolute neutrophil count (ANC). Adjuvant G-CSF was given to all subjects and stopped once TLC normalized. SPSS v22 was used to calculate mean G-CSF treatment duration and rise in ANC. A Pearson correlation coefficient and simple linear regression were computed to assess the relationship between pre-GCSF ANC and the duration of treatment with GCSF. Comparison of subgroups with respect to rise in ANC was done using independent samples T-test. Results: The mean duration of G-CSF treatment was 1.82±0.81 days (1.0 - 4.0). Neutropenic neonates constituted 49% (n=25). The Pearson correlation coefficient showed a positive but negligible and non-significant correlation between the two variables, r = 0.070, n = 51, p = 0.625. A non-significant regression equation was found (F(1,49) = 0.242,p=0.625) with an R2 of 0.005. There was a 7.06±4.5 fold rise in ANC in the neutropenic subgroup compared to the 4.5±3.1 fold rise in the non-neutropenic subgroup (p=0.04). Conclusions: The mean duration for recovery from leukopenia with G-CSF treatment in neonatal sepsis was less than 2 days and had no significant relationship with pre-GCSF absolute neutrophil count. The neutrophilic response was significantly higher in neutropenic compared to non-neutropenic neonates. As GCSF made no difference to the outcome in terms of mortality, its routine use is not recommended in leukopenic neonatal sepsis.
Publication Details
Page(s) 1613-1617
DOI DOI not available
Published Journal: Journal of Pakistan Medical Association, Volume: 68, Issue: 11, Year: 2018

Request the full text from PASTIC

Keywords
neutropenia, Granulocyte Colony-Stimulating Factor.
References
SahaSK,El ArifeenS,SchragSJ, 2016.Aetiology of Neonatal Infection in South Asia (ANISA): An Initiative to Identify Appropriate Program Priorities to Save Newborns,Pediatr Infect Dis J 35 S6 -8
FolgoriL,BielickiJ,HeathPT,SharlandM, 2017.Antimicrobial-resistant Gram-negative infections in neonates_ burden of disease and challenges in treatment,Curr Opin Infect Dis 30 281 -8
DownieL,ArmientoR,SubhiR,KellyJ,CliffordV,DukeT., 2013.Communityacquired neonatal and infant sepsis in developing countries: efficacy of WHO's currently recommended antibiotics--systematic review and meta-analysis,Arch Dis Child 98 146 -54
ShippKD,ChiangT,KarasickS,QuickK,NguyenST,CanteyJB, 2016.Antibiotic Stewardship Challenges in a Referral Neonatal Intensive Care Unit,Am J Perinatol 33 518 -24
ZervouFN,ZacharioudakisIM,ZiakasPD,MylonakisE., 2014.MRSA colonization and risk of infection in the neonatal and pediatric ICU: a meta-analysis,Pediatrics 133 e1015 -23
VerstraeteEH,BlotK,MahieuL,VogelaersD,Blot S, 2015.Prediction models for neonatal health care-associated sepsis: a meta-analysis,Pediatrics 135 e1002 -14
SharmaD,FarahbakhshN,ShastriS,SharmaP, 2017.Biomarkers for diagnosis of neonatal sepsis: a literature review,J Matern Fetal Neonatal Med 20 1 -37
Maheshwari, 2014.A. Neutropenia in the newborn,Curr Opin Hematol 21 43 -9
FunkeA,BernerR,TraichelB,SchmeisserD,LeititisJU,NiemeyerCM, 2000.Frequency, natural course, and outcome of neonatal neutropenia,Pediatrics 106 45 -51
KoenigJM,ChristensenRD, 1989.Incidence, neutrophil kinetics, and natural history of neonatal neutropenia associated with maternal hypertension,N Engl J Med 321 557 -62
TaylorJE,TanK,LaiNM,McDonaldSJ, 2015.Antibiotic lock for the prevention of catheter-related infection in neonates,Cochrane Database Syst Rev 6 CD010336 -
TanB,ZhangF,ZhangX,HuangYL,GaoYS,LiuX, 2014.Risk factors for ventilator-associated pneumonia in the neonatal intensive care unit: A meta-analysis of observational studies,Eur J Pediatr 173 427 -34
GillanER,ChristensenRD,SuenY,EllisR,van de VenC,Cairo MS, 1994.A randomized, placebo-controlled trial of recombinant human granulocyte colony-stimulating factor administration in newborn infants with presumed sepsis: significant induction of peripheral and bone marrow neutrophilia,Blood 84 1427 -33
CarrR,ModiN,DoréC., 2003.G-CSF and GM-CSF for treating or preventing neonatal infections,Cochrane Database Syst Rev CD003066 -
LeeJA,SauerB,TuminskiW,CheongJ,Fitz-HenleyJ,MayersM, 2017.Effectiveness of Granulocyte Colony-Stimulating Factor in Hospitalized Infants with Neutropenia,Am J Perinatol 34 458 -464
GleasonCA,DevaskarSU, 2012.Neonatal leukocyte physiology and disorders,Avery's Diseases of the Newborn 1110 -
SiddiquiT,BurneyIA,KakepotoGN,KhurshidM,SalamA,SmegoRAJ, 2002.Lack of benefit of granulocyte macrophage or granulocyte colony stimulating factor in patients with febrile neutropenia,J Pak Med Assoc 52 206 -10
ChannaJ,HashmiKZ, 2002.Role of Recombinant Granulocyte - Macrophage Colony - Stimulating factors in reducing the duration of Neutropenia,J Coll Physicians Surg Pak 12 538 -41
VandenbrouckeJP,von ElmE,AltmanDG,GøtzschePC,MulrowCD,PocockSJ, 2007.Strengthening the Reporting of Observational Studies in Epidemiology (STROBE)_ Explanation and Elaboration,PLoS Med 4 e297 -
ChaudhuriJ,MitraS,MukhopadhyayD,ChakrabortyS,ChatterjeeS., ., -
2012.Granulocyte Colony-stimulating Factor for Preterms with Sepsis and Neutropenia_ A Randomized Controlled Trial,J Clin Neonatol 1 202 -6
BorjianyazdiL,FroomandiM,Noori ShadkamM,HashemiA,FallahR, 2013.Effect of Granulocyte Colony Stimulating Factor Administration on Preterm Infant with Neutropenia and Clinical Sepsis_ A Randomized Clinical Trial,Iran J Ped Hematol Oncol 3 64 -8
KücüködükS1,SezerT,YildiranA,AlbayrakD.,Randomized, 2002.-controlled trial of early administration of recombinant human granulocyte colony-stimulating factor to nonneutropenic preterm newborns between 33 and 36 weeks with presumed sepsis,Scand J Infect Dis 34 893 -7
BerezinEN,SolórzanoF, 2014.Gram-negative infections in pediatric and neonatal intensive care units of Latin America,J Infect Dev Ctries 8 942 -53
0

Citations

0

Downloads

161

Views